Oil Finishes Week Lower

Oil fell today as ample U.S. stockpiles countered concerns OPEC could cut production again as the world's top energy consumer heads into winter.

Bulging oil inventories have pushed crude prices from record highs over $78 a barrel in July, with U.S. stocks near peaks not reached since 1991 ahead of winter.

But high consumer nation stocks have prompted some OPEC members to call for production cuts. OPEC President Edmund Daukoru said on Friday he wanted the group to trim output when it meets on Dec. 14, deepening a 1.2 million barrel per day cut agreed upon in October.

"I favor a cut," Daukoru told reporters in Abuja. "The market is still soft ... I'm not comfortable."

"We hope that if we moderate supply a bit, if we don't flood the market, some mop up will take place as winter really kicks in," he added.

A senior OPEC delegate earlier on Friday told Reuters that there was a "strong possibility" the group would trim output further to bring down high global inventories.

"Everybody knows that stock levels are higher than they should be," he said.

But U.S. Energy Secretary Sam Bodman said today OPEC should not reduce output at its next meeting.

"I don't agree with that," Bodman said, referring to Daukoru's comments, adding OPEC should "continue to keep markets well-supplied."

Ken Hasegawa, a manager at Japan's Himawari CX, said OPEC needed to cut at least 500,000 barrels per day to maintain the current price level.

"I think OPEC will cut production to support prices till the second quarter of 2007. The supply side is too strong right now," he said.

But some analysts believe OPEC will refrain from taking action next week as the market has yet to fully absorb its last cut, initiated on Nov. 1.

"My guess is they won't do anything. If you consider there has only been five weeks since the last cut, it's a bit early to judge the effects," said ABN AMRO analyst Geoff Pyne.

Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Martin Mucci, Paychex CEO, explains why the small business jobs report is showing mixed results for employment growth in August.

  • A new class of drugs which aim to lower levels of LDL are being pursued by multiple pharma companies and it could be a $10 billion market. Leonard Schleifer, Regeneron CEO, discusses what is known about bad cholesterol, and competition in the space.

  • Jeremy Siegel, Wharton School Professor of Finance, shares his view of the U.S. economy and market trends.